301 related articles for article (PubMed ID: 34128045)
1. Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.
Patel AG; Nehete PN; Krivoshik SR; Pei X; Cho EL; Nehete BP; Ramani MD; Shao Y; Williams LE; Wisniewski T; Scholtzova H
Brain; 2021 Aug; 144(7):2146-2165. PubMed ID: 34128045
[TBL] [Abstract][Full Text] [Related]
2. Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.
Scholtzova H; Do E; Dhakal S; Sun Y; Liu S; Mehta PD; Wisniewski T
J Neurosci; 2017 Jan; 37(4):936-959. PubMed ID: 28123027
[TBL] [Abstract][Full Text] [Related]
3. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.
Scholtzova H; Chianchiano P; Pan J; Sun Y; Goñi F; Mehta PD; Wisniewski T
Acta Neuropathol Commun; 2014 Sep; 2():101. PubMed ID: 25178404
[TBL] [Abstract][Full Text] [Related]
4. Cerebral beta-amyloid angiopathy in aged squirrel monkeys.
Elfenbein HA; Rosen RF; Stephens SL; Switzer RC; Smith Y; Pare J; Mehta PD; Warzok R; Walker LC
Histol Histopathol; 2007 Feb; 22(2):155-67. PubMed ID: 17149688
[TBL] [Abstract][Full Text] [Related]
5. Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (
Nehete PN; Williams LE; Chitta S; Nehete BP; Patel AG; Ramani MD; Wisniewski T; Scholtzova H
Front Aging Neurosci; 2020; 12():36. PubMed ID: 32194391
[TBL] [Abstract][Full Text] [Related]
6. The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.
Kövari E; Herrmann FR; Hof PR; Bouras C
Neuropathol Appl Neurobiol; 2013 Aug; 39(5):498-509. PubMed ID: 23163235
[TBL] [Abstract][Full Text] [Related]
7. Animal models of cerebral beta-amyloid angiopathy.
Walker LC
Brain Res Brain Res Rev; 1997 Sep; 25(1):70-84. PubMed ID: 9370051
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization.
Zotova E; Bharambe V; Cheaveau M; Morgan W; Holmes C; Harris S; Neal JW; Love S; Nicoll JA; Boche D
Brain; 2013 Sep; 136(Pt 9):2677-96. PubMed ID: 23943781
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy.
Heuer E; Jacobs J; Du R; Wang S; Keifer OP; Cintron AF; Dooyema J; Meng Y; Zhang X; Walker LC
J Alzheimers Dis; 2017; 57(2):519-530. PubMed ID: 28269776
[TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with five vascular risk factors causes cerebral amyloid angiopathy but no Alzheimer pathology in C57BL6 mice.
Foidl BM; Humpel C
Brain Behav Immun; 2019 May; 78():52-64. PubMed ID: 30664922
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's pathology targets distinct memory networks in the ageing brain.
Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
[TBL] [Abstract][Full Text] [Related]
12. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
[TBL] [Abstract][Full Text] [Related]
13. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?
Lemere CA; Oh J; Stanish HA; Peng Y; Pepivani I; Fagan AM; Yamaguchi H; Westmoreland SV; Mansfield KG
Rejuvenation Res; 2008 Apr; 11(2):321-32. PubMed ID: 18341428
[TBL] [Abstract][Full Text] [Related]
14. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease.
Nicoll JAR; Buckland GR; Harrison CH; Page A; Harris S; Love S; Neal JW; Holmes C; Boche D
Brain; 2019 Jul; 142(7):2113-2126. PubMed ID: 31157360
[TBL] [Abstract][Full Text] [Related]
15. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.
Mackic JB; Bading J; Ghiso J; Walker L; Wisniewski T; Frangione B; Zlokovic BV
Vascul Pharmacol; 2002 Jun; 38(6):303-13. PubMed ID: 12529925
[TBL] [Abstract][Full Text] [Related]
16. Brain clearance of Alzheimer's amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy.
Bading JR; Yamada S; Mackic JB; Kirkman L; Miller C; Calero M; Ghiso J; Frangione B; Zlokovic BV
J Drug Target; 2002 Jun; 10(4):359-68. PubMed ID: 12164385
[TBL] [Abstract][Full Text] [Related]
17. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.
Weller RO; Boche D; Nicoll JA
Acta Neuropathol; 2009 Jul; 118(1):87-102. PubMed ID: 19234858
[TBL] [Abstract][Full Text] [Related]
18. Prolonged diet induced obesity has minimal effects towards brain pathology in mouse model of cerebral amyloid angiopathy: implications for studying obesity-brain interactions in mice.
Zhang L; Dasuri K; Fernandez-Kim SO; Bruce-Keller AJ; Freeman LR; Pepping JK; Beckett TL; Murphy MP; Keller JN
Biochim Biophys Acta; 2013 Sep; 1832(9):1456-62. PubMed ID: 23313575
[TBL] [Abstract][Full Text] [Related]
19. Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease.
Rosen RF; Tomidokoro Y; Farberg AS; Dooyema J; Ciliax B; Preuss TM; Neubert TA; Ghiso JA; LeVine H; Walker LC
Neurobiol Aging; 2016 Aug; 44():185-196. PubMed ID: 27318146
[TBL] [Abstract][Full Text] [Related]
20. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy.
Taylor X; Cisternas P; You Y; You Y; Xiang S; Marambio Y; Zhang J; Vidal R; Lasagna-Reeves CA
J Neuroinflammation; 2020 Jul; 17(1):223. PubMed ID: 32711525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
